CasNo.1169630-82-3,Semaglutide main chain (Arg34-GLP(9-37))，N-3,(1169630-82-3) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: 99%

Keywords

Semaglutide main chain (Arg34-GLP(9-37))，N-3 High Quality lower price

Quick Details

Appearance:White Powder
Application:glycemic control
PackAge:plastic bottle
ProductionCapacity:1|Kilogram|Day
Storage:0-8°C
Transportation:Cold-chain transportation

Superiority:

Our Advantages

Goods quality

1. Product has COA, and DMF
2. Our Plants are Pharmaceutical GMP Plant
3. All products purity over 99%

Custom-made service

1. Add customer's logo
2. Redesign label, packing box as customer's requirements
3. Cap color can be customized

Shipping service

1. Goods shipped in 1-7 days after get payment.
2. Small order ship by express door to door.
3. Goods arrive in 5-12 days

FAQs

Q1: What's your MOQ?
A: It depends on different products, we can accept sample order.

Q2:How to start orders or make payments?
A: Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T, Paypal.

Q3.What quality control data do you provide for peptides?
A: Quality control (QC) data provided with peptide includes mass spectral (MS) and HPLC analyses determining composition and purity. Amino acid analysis (AAA) and peptide content are available upon request with an added cost for each test.

Q4: How do you treat quality complaint?
A: First of all, our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement or refund your loss.

Q5.Is your peptide chemically synthesized or biologically synthesized？
A: Our peptide is fully bio-synthesized.

Q6. Can I visit your factory?
A: Our factory is located in Nantong, China. We offers factory visiting for important customers.

Details:

Semaglutide Introduction

Semaglutide for the use of weight loss

Semaglutide was approved by FDA for the use of weight loss in June 2021. Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA) administered once a week.

5 ways Semaglutide promotes weight loss

1. Appetite regulation

Semaglutide mimics the natural hormone GLP-1, which is produced in the gut and plays a key role in regulating appetite and food intake. GLP-1 receptors are found in the brain, particularly in the hypothalamus and brainstem, which are involved in controlling hunger and satiety. By activating the GLP-1 receptors in the brain, semaglutide helps reduce feelings of hunger, leading to decreased calorie intake.

2. Glucagon suppression

Glucagon is a hormone that is produced by the pancreas and plays a key role in regulating blood sugar levels by stimulating the liver to release glucose into the bloodstream. When semaglutide is administered, it works by binding to GLP-1 receptors in the pancreas, which leads to the suppression of the release of glucagon. By suppressing the release of glucagon, semaglutide helps to lower blood sugar levels in individuals with diabetes.

3. Glucose-dependent insulin secretion

Semaglutide enhances the secretion of insulin in a glucose-dependent manner, meaning it increases insulin release only when blood glucose levels are elevated. This helps to improve blood sugar levels and reduce the risk of hypoglycemia (low blood sugar).

4. Energy expenditure and lipid metabolism

Semaglutide has been shown to increase energy expenditure and promote fat burning, leading to reductions in body weight and improvements in body composition. It may also have a positive impact on lipid metabolism, contributing to favorable changes in cholesterol and triglyceride levels.

5. Delayed gastric emptying

Semaglutide slows down the rate at which food leaves the stomach and enters the small intestine, a process known as delayed gastric emptying. This delayed gastric emptying leads to a prolonged sense of fullness and satiety, further reducing food intake.

Company Introduction

Our factory is located in Nantong, Jiangsu, China.

Technology: Specialized in bio-synthesized peptide

Business: Provides Drug Peptide Product and CMC Service for Drug Peptide

Team: well-known GMP experts and class-leading scientists

Facility: 3,300m² R&D center, 6,700m² workshop and a 20,000m² manufacturing facility

Objective: Redefining the peptide industry through technological innovation and industrialization